Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model
- PMID: 32937112
- DOI: 10.1016/j.ejphar.2020.173555
Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model
Abstract
Renal fibrosis is a major pathological process in the progression of various chronic kidney diseases to end-stage renal disease (ESRD). Growing evidence has suggested that gut microbiota dysbiosis is closely related to ESRD. However, the interplay between altered fecal microbiome and metabolome during the renal fibrotic process remains unclear. Herein, an integrated approach of 16S ribosomal DNA sequencing combined with an ultra-high performance liquid chromatography-mass spectrometry-based metabolomics platform was applied to investigate the dynamic changes of fecal microbiota and metabolites throughout renal fibrosis progression in a mouse model of unilateral ureteral obstruction (UUO). The composition of gut microbiota changed markedly before and after UUO surgery. UUO mice showed a decrease in short-chain fatty acids-producing genera, including Bacteroides, Prevotellaceae_UCG-001, Roseburia, and Lachnospiraceae_NK4A136_group, as well as an increase in the genera Parasutterella and Alistipes, which changed dynamically over time. Additionally, 41 differential metabolites, mainly involved in 12 metabolic pathways, including inositol phosphate metabolism, primary bile acid biosynthesis, biosynthesis of unsaturated fatty acids, taurine and hypotaurine metabolism, purine metabolism, were identified in the UUO mice before and after surgery. Four fecal metabolites, myo-inositol, dodecanoic acid, N-acetylputrescine, and anthranilic acid, were positively associated with the progression of renal fibrosis. Moreover, by using multi-omics analyses, we found the alteration in UUO-related gut microbiota was correlated with a change in fecal metabolites. Therefore, our results provide insights into disturbances of the microbiome-metabolome interface in the progression of UUO-related renal fibrosis.
Keywords: Fecal microbiome; Metabolome; Multi-omics analysis; Renal fibrosis; Unilateral ureteral obstruction.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis.Exp Mol Med. 2019 Mar 27;51(3):1-18. doi: 10.1038/s12276-019-0234-2. Exp Mol Med. 2019. PMID: 30918245 Free PMC article.
-
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8. J Ethnopharmacol. 2019. PMID: 31401318
-
Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.J Pharm Biomed Anal. 2017 May 10;138:231-239. doi: 10.1016/j.jpba.2017.02.008. Epub 2017 Feb 10. J Pharm Biomed Anal. 2017. PMID: 28219800
-
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.Kidney Int. 2009 Jun;75(11):1145-1152. doi: 10.1038/ki.2009.86. Epub 2009 Apr 1. Kidney Int. 2009. PMID: 19340094 Review.
-
Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis.Free Radic Biol Med. 2021 Aug 20;172:65-81. doi: 10.1016/j.freeradbiomed.2021.05.034. Epub 2021 May 30. Free Radic Biol Med. 2021. PMID: 34077780 Review.
Cited by
-
Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia.Heliyon. 2023 Sep 20;9(9):e20328. doi: 10.1016/j.heliyon.2023.e20328. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809388 Free PMC article.
-
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.Front Pharmacol. 2021 Nov 24;12:757508. doi: 10.3389/fphar.2021.757508. eCollection 2021. Front Pharmacol. 2021. PMID: 34899312 Free PMC article.
-
Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis.Front Med (Lausanne). 2025 Apr 28;12:1489100. doi: 10.3389/fmed.2025.1489100. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40357302 Free PMC article.
-
Reno-Protective Effect of Low Protein Diet Supplemented With α-Ketoacid Through Gut Microbiota and Fecal Metabolism in 5/6 Nephrectomized Mice.Front Nutr. 2022 Jun 30;9:889131. doi: 10.3389/fnut.2022.889131. eCollection 2022. Front Nutr. 2022. PMID: 35845811 Free PMC article.
-
Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.Ann Transl Med. 2022 Jul;10(13):750. doi: 10.21037/atm-22-2926. Ann Transl Med. 2022. PMID: 35957707 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical